Molecular Partners AG (MOLN)
6.12
+0.76
(+14.18%)
USD |
NASDAQ |
Nov 01, 16:00
6.15
+0.03
(+0.49%)
After-Hours: 20:00
Molecular Partners Market Cap: 203.08M for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 203.08M |
| October 31, 2024 | 177.86M |
| October 30, 2024 | 204.07M |
| October 29, 2024 | 205.73M |
| October 28, 2024 | 214.36M |
| October 25, 2024 | 215.36M |
| October 24, 2024 | 199.76M |
| October 23, 2024 | 188.13M |
| October 22, 2024 | 218.01M |
| October 21, 2024 | 224.98M |
| October 18, 2024 | 161.60M |
| October 17, 2024 | 165.25M |
| October 16, 2024 | 164.25M |
| October 15, 2024 | 164.25M |
| October 14, 2024 | 157.62M |
| October 11, 2024 | 157.62M |
| October 10, 2024 | 157.62M |
| October 09, 2024 | 162.80M |
| October 08, 2024 | 162.80M |
| October 07, 2024 | 157.95M |
| October 04, 2024 | 166.58M |
| October 03, 2024 | 151.98M |
| October 02, 2024 | 153.64M |
| October 01, 2024 | 158.95M |
| September 30, 2024 | 168.80M |
| Date | Value |
|---|---|
| September 27, 2024 | 168.24M |
| September 26, 2024 | 155.63M |
| September 25, 2024 | 153.30M |
| September 24, 2024 | 166.42M |
| September 23, 2024 | 156.95M |
| September 20, 2024 | 154.96M |
| September 19, 2024 | 154.96M |
| September 18, 2024 | 160.60M |
| September 17, 2024 | 168.57M |
| September 16, 2024 | 172.88M |
| September 13, 2024 | 173.21M |
| September 12, 2024 | 183.50M |
| September 11, 2024 | 182.50M |
| September 10, 2024 | 186.15M |
| September 09, 2024 | 186.65M |
| September 06, 2024 | 182.84M |
| September 05, 2024 | 191.96M |
| September 04, 2024 | 196.18M |
| September 03, 2024 | 187.15M |
| August 30, 2024 | 188.48M |
| August 29, 2024 | 215.02M |
| August 28, 2024 | 210.05M |
| August 27, 2024 | 229.62M |
| August 26, 2024 | 205.40M |
| August 23, 2024 | 206.73M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
109.12M
Minimum
Apr 19 2024
1.030B
Maximum
Jan 14 2022
307.98M
Average
215.51M
Median
Market Cap Benchmarks
| AC Immune SA | 296.82M |
| CRISPR Therapeutics AG | 4.323B |
| Addex Therapeutics Ltd | 11.44M |
| NLS Pharmaceutics Ltd | 13.73M |
| MoonLake Immunotherapeutics | 2.941B |
Market Cap Related Metrics
| PS Ratio | 22.67 |
| Price to Book Value | 1.174 |
| Price | 6.12 |
| Earnings Yield | -32.21% |